Programmed Cell Death Protein 4 (PDCD4) Peptide
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Programmed Cell Death Protein 4 (PDCD4) Peptide is a synthetic peptide. This peptide is used in the production of
Documents del producto
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Programmed Cell Death Protein 4 (PDCD4) |
| Host | Synthetic |
| Assay Type | Activity: Not tested. Sequence Fragment: Internal region: DSYKGTVDCVQAR |
| Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Size 1 | 100 µg |
| Form | Lyophilized |
| Tested Applications | P-ELISA |
| Buffer | Prior to lyophilization: Deionized water. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 27250, 18569, 64031 |
| NCBI Accession | NP_055271.2, NP_663314.1, NP_001186421.1 |
| Background | Protein PDCD4 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. Reconstitute in deionized water. |
Descripción
Related Products
Human PDCD4 (Programmed cell death protein 4) ELISA Kit
Ver Producto
PDCD4 antibody
Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA(By similarity).
Ver ProductoPDCD4 antibody
Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA(By similarity).
Ver Producto